Coccidioidomycosis: Changing perceptions and creating opportunities for its control

Research output: Chapter in Book/Report/Conference proceedingConference contribution

20 Citations (Scopus)

Abstract

The perceptions of coccidioidomycosis as a medical problem has undergone sequential and dramatic metamorphoses since its first description more than a century ago. First thought to be rare and lethal, coccidioidomycosis was subsequently found to be common and often mild. During World War II, its overall impact upon large populations came sharply into focus and the consequences for public health became clearer. Early treatments had significant limitations and toxicities, and therefore treatment of coccidioidomycosis was reserved for only the sickest patients. Since then, safer oral therapies have become commonplace. Despite their availability, there has been no investigation of their use in the less severe and much more common early infections. Even newer drugs such as nikkomycin Z, which might actually cure infections, until very recently have had trouble finding a sponsor to move it through clinical trials. Perceptions once formed by the understanding of coccidioidomycosis as a medical problem now appear to hinder the future study of newer therapeutic opportunities. It is suggested in this review that it is time to revisit and possibly change these perceptions if we are to improve our care of patients.

Original languageEnglish (US)
Title of host publicationAnnals of the New York Academy of Sciences
Pages1-18
Number of pages18
Volume1111
DOIs
StatePublished - Sep 2007

Publication series

NameAnnals of the New York Academy of Sciences
Volume1111
ISSN (Print)00778923
ISSN (Electronic)17496632

Fingerprint

Coccidioidomycosis
Medical problems
Public health
Toxicity
Availability
World War II
Therapeutics
Infection
Pharmaceutical Preparations
Patient Care
Public Health
Clinical Trials
Population
nikkomycin

Keywords

  • Antifungal therapies
  • Medical history
  • Public health

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Galgiani, J. N. (2007). Coccidioidomycosis: Changing perceptions and creating opportunities for its control. In Annals of the New York Academy of Sciences (Vol. 1111, pp. 1-18). (Annals of the New York Academy of Sciences; Vol. 1111). https://doi.org/10.1196/annals.1406.041

Coccidioidomycosis : Changing perceptions and creating opportunities for its control. / Galgiani, John N.

Annals of the New York Academy of Sciences. Vol. 1111 2007. p. 1-18 (Annals of the New York Academy of Sciences; Vol. 1111).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Galgiani, JN 2007, Coccidioidomycosis: Changing perceptions and creating opportunities for its control. in Annals of the New York Academy of Sciences. vol. 1111, Annals of the New York Academy of Sciences, vol. 1111, pp. 1-18. https://doi.org/10.1196/annals.1406.041
Galgiani JN. Coccidioidomycosis: Changing perceptions and creating opportunities for its control. In Annals of the New York Academy of Sciences. Vol. 1111. 2007. p. 1-18. (Annals of the New York Academy of Sciences). https://doi.org/10.1196/annals.1406.041
Galgiani, John N. / Coccidioidomycosis : Changing perceptions and creating opportunities for its control. Annals of the New York Academy of Sciences. Vol. 1111 2007. pp. 1-18 (Annals of the New York Academy of Sciences).
@inproceedings{9cfb31425b2f4dfaa1ba107434d1e3e2,
title = "Coccidioidomycosis: Changing perceptions and creating opportunities for its control",
abstract = "The perceptions of coccidioidomycosis as a medical problem has undergone sequential and dramatic metamorphoses since its first description more than a century ago. First thought to be rare and lethal, coccidioidomycosis was subsequently found to be common and often mild. During World War II, its overall impact upon large populations came sharply into focus and the consequences for public health became clearer. Early treatments had significant limitations and toxicities, and therefore treatment of coccidioidomycosis was reserved for only the sickest patients. Since then, safer oral therapies have become commonplace. Despite their availability, there has been no investigation of their use in the less severe and much more common early infections. Even newer drugs such as nikkomycin Z, which might actually cure infections, until very recently have had trouble finding a sponsor to move it through clinical trials. Perceptions once formed by the understanding of coccidioidomycosis as a medical problem now appear to hinder the future study of newer therapeutic opportunities. It is suggested in this review that it is time to revisit and possibly change these perceptions if we are to improve our care of patients.",
keywords = "Antifungal therapies, Medical history, Public health",
author = "Galgiani, {John N}",
year = "2007",
month = "9",
doi = "10.1196/annals.1406.041",
language = "English (US)",
isbn = "1573316881",
volume = "1111",
series = "Annals of the New York Academy of Sciences",
pages = "1--18",
booktitle = "Annals of the New York Academy of Sciences",

}

TY - GEN

T1 - Coccidioidomycosis

T2 - Changing perceptions and creating opportunities for its control

AU - Galgiani, John N

PY - 2007/9

Y1 - 2007/9

N2 - The perceptions of coccidioidomycosis as a medical problem has undergone sequential and dramatic metamorphoses since its first description more than a century ago. First thought to be rare and lethal, coccidioidomycosis was subsequently found to be common and often mild. During World War II, its overall impact upon large populations came sharply into focus and the consequences for public health became clearer. Early treatments had significant limitations and toxicities, and therefore treatment of coccidioidomycosis was reserved for only the sickest patients. Since then, safer oral therapies have become commonplace. Despite their availability, there has been no investigation of their use in the less severe and much more common early infections. Even newer drugs such as nikkomycin Z, which might actually cure infections, until very recently have had trouble finding a sponsor to move it through clinical trials. Perceptions once formed by the understanding of coccidioidomycosis as a medical problem now appear to hinder the future study of newer therapeutic opportunities. It is suggested in this review that it is time to revisit and possibly change these perceptions if we are to improve our care of patients.

AB - The perceptions of coccidioidomycosis as a medical problem has undergone sequential and dramatic metamorphoses since its first description more than a century ago. First thought to be rare and lethal, coccidioidomycosis was subsequently found to be common and often mild. During World War II, its overall impact upon large populations came sharply into focus and the consequences for public health became clearer. Early treatments had significant limitations and toxicities, and therefore treatment of coccidioidomycosis was reserved for only the sickest patients. Since then, safer oral therapies have become commonplace. Despite their availability, there has been no investigation of their use in the less severe and much more common early infections. Even newer drugs such as nikkomycin Z, which might actually cure infections, until very recently have had trouble finding a sponsor to move it through clinical trials. Perceptions once formed by the understanding of coccidioidomycosis as a medical problem now appear to hinder the future study of newer therapeutic opportunities. It is suggested in this review that it is time to revisit and possibly change these perceptions if we are to improve our care of patients.

KW - Antifungal therapies

KW - Medical history

KW - Public health

UR - http://www.scopus.com/inward/record.url?scp=35348877881&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35348877881&partnerID=8YFLogxK

U2 - 10.1196/annals.1406.041

DO - 10.1196/annals.1406.041

M3 - Conference contribution

C2 - 17344530

AN - SCOPUS:35348877881

SN - 1573316881

SN - 9781573316880

VL - 1111

T3 - Annals of the New York Academy of Sciences

SP - 1

EP - 18

BT - Annals of the New York Academy of Sciences

ER -